FDA Approves First Treatment for Adult Onset Still’s DiseaseActive Still's disease, Adult-Onset Still's Disease (AOSD), Approvals, Arthritis, Autoinflammatory Diseases, FDA, FDA/Regulatory, Fever, Rare Autoinflammatory Diseases, TherapeuticsThe U.S. Food and Drug Administration approved Ilaris (canakinumab) injection for the treatment of Active Still’s disease, including Adult-Onset Still’s Disease. Read more June 16, 2020/by PR Newswire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 PR Newswire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png PR Newswire2020-06-16 15:45:542020-06-20 19:01:20FDA Approves First Treatment for Adult Onset Still’s Disease